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Abstract 29 
 30 
The effects of cocoa feeding against N-nitrosodiethylamine (DEN)-induced liver injury were 31 
studied in rats. Animals were divided into five groups. Groups 1 and 2 were fed with standard 32 
and cocoa diet, respectively. Groups 3 and 4 were injected with DEN at 2 and 4 weeks, and 33 
fed with standard and cocoa diet, respectively. Group 5 was treated with DEN, received the 34 
standard diet for 4 weeks and then it was replaced by the cocoa-diet. DEN-induced hepatic 35 
damage caused a significant increase in damage markers, as well as a decrease in the hepatic 36 
glutathione, diminished levels of p-ERK and enhanced protein carbonyl content, caspase-3 37 
activity and values of p-AKT and p-JNK. The cocoa-rich diet prevented the reduction of 38 
hepatic glutathione concentration and catalase and GPx activities in DEN-injected rats, as 39 
well as diminished protein carbonyl content, caspase-3 activity, p-AKT and p-JNK levels, and 40 
increased GST activity. However, cocoa administration did not abrogate the DEN-induced 41 
body weight loss and the increased levels of hepatic-specific enzymes and LDH. These results 42 
suggested that cocoa-rich diet attenuates the DEN-induced liver injury. 43 
44 
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Introduction 45 
 46 
Chronic liver damage is a worldwide common pathology characterized by inflammation and 47 
fibrosis that can lead to chronic hepatitis, cirrhosis and cancer (Köhle, C. et al., 2008, 48 
Tessitore, L. and Bollito, E., 2006, Thorgeirsson, S. and Grisham, J., 2002). It has been well 49 
established that oxidative stress plays a causative role at the initiation, promotion and 50 
progression of hepatic diseases (Ramos, S., 2008, Vitaglione, P. et al., 2004) and that the liver 51 
is the main target for several toxic agents that can provoke free radical-mediated apoptosis 52 
(Jaeschke, H. et al., 2002). 53 
Cocoa and its derived products are widely consumed in Europe and the United States 54 
(Vinson, J. et al., 2006) and they have increasingly attracted researchers, food manufacturers, 55 
as well as consumers due to their biological properties, which have been mostly related to its 56 
phenolic compounds (Lamuela-Raventós, R. et al., 2005). Cocoa flavonoids can influence 57 
several important biological functions by their free-radical scavenging ability or through the 58 
regulation of signal transduction pathways to stimulate apoptosis and/or to inhibit 59 
inflammation and proliferation in different human cancer cell lines (Lamuela-Raventós, R. et 60 
al., 2005, Martin, M. et al., 2009, Martin, M. et al., 2008, Ramos, S., 2007, Ramos, S., 2008). 61 
Therefore, cocoa phenolic compounds have been suggested not only as potential protective 62 
and even therapeutic agents to reduce liver damage (Ramos, S., 2008, Vitaglione, P. et al., 63 
2004). 64 
The modulation of phase I [glutathione reductase (GR), glutathione peroxidase (GPx) and 65 
catalase (CAT)] and phase II [glutathione-S-transferase (GST)] enzymes, and gluthatione 66 
(GSH) levels play a primary role in the balance of the redox status through the reduction of 67 
reactive oxygen spices (ROS) and peroxides produced in the organism, as well as in the 68 
detoxification of xenobiotics (Ramiro Puig, E. et al., 2007, Ramos, S., 2008). Cocoa has been 69 
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shown to enhance the activity of phase I enzymes in hepatic and thymocyte cells, respectively 70 
(Martin, M. et al., 2009, Ramiro Puig, E. et al., 2007), and it may also induce cell survival and 71 
proliferation, as well as protective effects, through the modulation of different transduction 72 
pathways, such as AKT and MAPKs (Martin, M. et al., 2009, Ramiro-Puig, E. et al., 2009). 73 
Additionally, upregulation of phase I and II enzymes mediated by MAPKs and/or AKT has 74 
been reported for different polyphenols (Masella, R. et al., 2005, Na, H. and Surh, Y., 2008). 75 
In this regard, induction of GPx and GR by cocoa has been shown to occur via ERK in 76 
hepatic cells (Martin, M. et al., 2009). Moreover, GST expression has been implicated in the 77 
regulation of cell proliferation and protection from apoptosis through JNK-mediated 78 
mechanisms (Holley, S.L. et al., 2007, Mates, J.M. et al., 2008). 79 
N-nitrosodiethylamine (DEN) is a potent hepatotoxic, carcinogen and mutagen (Chuang, S. et 80 
al., 2000, Köhle, C. et al., 2008, Sreepriya, M. and Bali, G., 2006, Tessitore, L. and Bollito, 81 
E., 2006). Human exposure could occur through the diet (meat, whiskey, etc.) (Hecht, S., 82 
1997, Sen, N. et al., 1980), in certain occupational settings, smoking or through the use of 83 
cosmetics, pharmaceutical products and agricultural chemicals (Hecht, S., 1997). DEN has 84 
been extensively used as an initiating carcinogen in experimental animal models (Chuang, S. 85 
et al., 2000, Köhle, C. et al., 2008, Ramakrishnan, G. et al., 2006, Sivaramakrishnan, V. et al., 86 
2008, Sreepriya, M. and Bali, G., 2005, Sreepriya, M. and Bali, G., 2006, Sundaresan, S. and 87 
Subramanian, P., 2008, Tessitore, L. and Bollito, E., 2006) and induces hepatic necrosis 88 
through metabolic activation by CYP2E1 in experimental animals (Kang, J. et al., 2007). 89 
Activation of DEN, which takes place mainly in liver microsomes (Kang, J. et al., 2007), has 90 
been shown to stimulate Kupfer cells leading to generate high levels of ROS, capable of 91 
damaging liver cells and participating in the induction of hepatocarcinogenesis (Kang, J. et 92 
al., 2007). It has been shown that a cocoa bean preparation protects against different types of 93 
cancers (Yamagishi, M. et al., 2002, Yamagishi, M. et al., 2003), as well as against a number 94 
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of hepatotoxic agents including nitrosamines (Amin, I. et al., 2004, Yamagishi, M. et al., 95 
2000). However, the mechanisms by which cocoa elicits such hepatoprotective and 96 
chemopreventive effects related to antioxidant defences, as well as survival/proliferation 97 
pathways, remain poorly understood. 98 
Thus, the aim of this study was to evaluate the protective effect of a cocoa-rich diet against 99 
DEN-induced liver toxicity. Here, we report that cocoa partly attenuates DEN-induced liver 100 
injury in rats via induction of antioxidant defence (GSH, CAT, GPx and GST) and 101 
modulation of signals related to cell death (caspase-3 and JNK) and survival/proliferation 102 
(AKT). 103 
104 
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Materials and Methods 105 
 106 
Materials and chemical 107 
N-nitrosodiethylamine (DEN) was purchased from Sigma Chemical (Madrid, Spain). Anti-108 
AKT and antiphospho-Ser473-AKT (p-AKT), anti-ERK1/2 and antiphospho-ERK1/2 (p-109 
ERKs) recognizing ERK1/2 phosphorylated Thr202/Thy204, anti-JNK1/2 and antiphospho-110 
JNK1/2 (p-JNKs) recognizing JNK1/2 phosphorylated Thr183/Tyr185 and anti-ß-actin were 111 
obtained from Cell Signaling Technology (9271, 9272, 9101, 9102, 9251, 9252, and 4697, 112 
respectively; Izasa, Madrid, Spain). Caspase-3 substrate (Ac-DEVD-AMC) was purchased 113 
from Pharmingen (San Diego, CA). Materials and chemicals for electrophoresis and the 114 
Bradford reagent were from BioRad (BioRad Laboratories S.A., Madrid, Spain). 115 
 116 
Cocoa 117 
Natural Forastero cocoa powder (Nutrexpa, Barcelona, Spain) was used for this study. It 118 
contains epicatechin (383.5 mg/100g), catechin (116 mg/100g) and procyanidins (254.5 119 
mg/100g) and non-flavonoid compounds such as theobromine. A detailed description of this 120 
cocoa is given elsewhere (Martin, M. et al., 2008). 121 
 122 
Animal treatments 123 
Forty five male Sprague-Dawley rats (6 weeks old) were obtained from the School of 124 
Medicine, Universidad Autónoma (Madrid, Spain). Animals were placed individually in 125 
stainless steel wire-bottomed metabolic cages housed in a room under controlled conditions 126 
(19-23 ºC, 50-60 % humidity and 12 h light/darkness cycles). 127 
Diets were prepared from a Fibre Free AIN-93M Purified Rodent Diet (Panlab S.L., 128 
Barcelona, Spain) providing all nutrients required by adult rats. Rats were randomly assorted 129 
into five different experimental groups (eight to ten animals per group) (Figure 1) and were 130 
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provided with food and water ad libitum. Initially, three groups received a standard diet (C, 131 
groups 1, 3 and 5) and two groups were fed with cocoa-rich diet (Ca, groups 2 and 4), 132 
containing the basal diet supplemented with 16 % powdered cocoa (providing 54.4 g of 133 
dietary fibre per Kg of diet), added as a source of polyphenols. In line with our previous 134 
research, this powdered supplement was formulated to provide 7.5 g of polyphenols per Kg of 135 
diet, since this percentage of cocoa supplementation improve the antioxidant defence system, 136 
the lipid profile and reduced the lipid peroxidation. (Lecumberri, E. et al., 2007). The 137 
composition of the diets is given in Table 1 and cocoa powder contains 26% proteins and 12% 138 
lipids. 139 
To induce hepatic damage, three groups of rats (groups 3-5) were injected intraperitoneally 140 
with 200 mg/Kg DEN diluted in saline on days 14 and 28. Rats in the non-DEN treated 141 
groups were injected with saline the same day. In addition, on day 28, group 5 was changed 142 
from control diet to cocoa diet after the second DEN injection (Figure 1) to test the potential 143 
therapeutic activity of the cocoa-rich diet. 144 
Animal weight and food intake were monitored daily for 6 weeks. Blood was harvested from 145 
the trunk after decapitation, and serum was separated by centrifugation at 1000 xg, 10 min, 146 
4ºC for further biochemical analysis. Livers were collected, weighted and frozen in liquid N2 147 
and stored at –80ºC. 148 
Animals were treated according to the Institutional Care Instructions (Bioethical Commission 149 
from Consejo Superior de Investigaciones Cientificas). 150 
 151 
Analysis of hepatic enzymes (AST, ALT, ALP) 152 
As markers for liver function in serum, the activity of aspartate transaminase (AST), alanine 153 
transaminase (ALT) and alkaline phosphatase (ALP) [expressed as Units (U)/L serum] were 154 
analysed. Serum AST was measured spectrophotometrically at 340 nm in the presence of -155 
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ketoglutarate, aspartate, NADH and malate dehydrogenase, following the method of Rej and 156 
Horder (Rej, R. and Horder, M., 1984). Serum ALT was assayed at 340 nm in the presence of 157 
-ketoglutarate, pyruvate, NADH and lactate dehydrogenase as described by Horder and Rej 158 
(Horder, M. and Rej, R., 1984). Serum ALP was analysed spectrophotometrically at 405 nm 159 
using the formation of p-nitrophenol from p-nitrophenylphosphate as a substrate (Principato, 160 
G.B. et al., 1985). Serum protein concentration was measured by the Bradford reagent. 161 
 162 
Determination of GSH 163 
The content of GSH was quantitated by the fluorometric assay of Hissin and Hilf (Hissin, P. 164 
and Hilf, R., 1976). The method takes advantage of the reaction of GSH with o-165 
phthalaldehyde (OPT) at pH 8.0, which generates fluorescence. 166 
Livers were homogenized (1:20 w/v) in 50 mM phosphate buffer pH 7.0, proteins precipitated 167 
with 5% trichloroacetic acid and then centrifuged for 30 min at 10.000 xg. Following, 50 µL 168 
of the clear supernatant were transferred to a 96 multiwell plate for the assay. Fluorescence 169 
was measured at an excitation wavelength of 340 nm and emission wavelength of 460 nm. 170 
The results were interpolated in a glutathione standard curve (5 ng-1 μg) and expressed as 171 
nmol GSH per milligram of protein, which was determined by the Bradford reagent. The 172 
precise protocol has been described elsewhere (Alia, M. et al., 2003, Alía, M. et al., 2006). 173 
 174 
Determination of GPx, GR, CAT and GST activities 175 
The activity of antioxidant enzymes (GPx, GR and catalase) was determined in liver 176 
homogenates. Livers (0.3 g) were homogenized (1:5 w/v) in 0.25 M Tris, 0.2 M sucrose and 177 
5 mM 1,4-dithiothreitol (DTT) buffer pH 7.4 and centrifuged at 3.000 xg for 15 min. 178 
Determination of GPx activity is based on the oxidation of GSH by GPx, using t-BOOH as a 179 
substrate, coupled to the disappearance of NADPH by GR (Gunzler, W. et al., 1974), 180 
Protective effects of cocoa in liver damage 
 9 
expressing the results as mU/mg protein. GR activity was determined by following the 181 
decrease in absorbance due to the oxidation of NADPH utilized in the reduction of oxidized 182 
glutathione (Goldberg, D. and Spooner, R.). The GR activity was expressed as μU/mg 183 
protein. Catalase (CAT) activity was determined by following the decomposition of H2O2 184 
measured as a decrease in absorbance at 240 nm (Aebi, H., 1987) and expressed as UI/mg 185 
protein. The methods have been previously described (Alia, M. et al., 2003, Alía, M. et al., 186 
2006). 187 
Analysis of GST was carried out in liver and serum by the Biovision Commercial kit GST 188 
fluorometric activity assay (Biovision, Mountain View, CA) and the activities were expressed 189 
as U/mg protein and mU/mg protein, respectively. Protein was measured by the Bradford 190 
reagent. 191 
 192 
Protein carbonyl determination in liver 193 
Protein oxidation of liver homogenates was measured as carbonyl groups content according to 194 
the method of Richert et al. (Richert, S. et al., 2002). Absorbance was measured at 360 nm 195 
and carbonyl content was expressed as nmol/mg protein using an extinction coefficient of 196 
22000 nmol L
-1
 cm
-1
. Protein in liver homogenates was determined by the Bradford reagent. 197 
 198 
Lactate Dehydrogenase (LDH) Leakage Assay 199 
Livers were homogenized (1:5 w/v) in 50 mM phosphate buffer (PBS) pH 7.5, centrifuged for 200 
30 min at 1000 xg and the supernatants collected. LDH was spectrophotometrically assayed 201 
in the samples by measuring the disappearance of NADH at 340 nm, as previously described 202 
(Alía, M. et al., 2006, Bergmeyer, H. and Bernt, E., 1974). The reaction mixture contained 5 203 
mM piruvate, 0.35 mM NADH, 84 mM Tris and 50 µg of protein per condition. Enzyme 204 
activity was calculated by using an extinction coefficient of 6.22 mM
-1
 cm
-1
 and expressed in 205 
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units using mg
-1
 protein. One unit of the enzyme activity is defined as the amount of enzyme 206 
required to oxidize 1 µmol NADH min
-1
. 207 
 208 
Liver caspase-3 activity 209 
Activation of caspase-3 was determined as previously described (Granado-Serrano, A. et al., 210 
2007). Briefly, livers were lysed (1:5 w/v) in a buffer containing 5 mM Tris (pH 8), 20 mM 211 
EDTA, and 0.5 % Triton X-100. The reaction mixture contained 20 mM HEPES (pH 7), 10 % 212 
glycerol, 2 mM DTT, 50 µg of protein per condition and 20 µM Ac-DEVDAMC (N-acetyl-213 
Asp-Glu-Val-Asp-7-amino-4-methylcoumarin) as substrate. Enzymatic activity was 214 
determined by measuring fluorescence at an excitation wavelength of 380 nm and an emission 215 
wavelength of 440 nm (Bio-Tek, Winooski, VT, USA). 216 
 217 
Preparation of cell lysates for Western blotting 218 
Samples of frozen liver were homogenized 1:10 (w:v) in extraction buffer [50 mM HEPES 219 
(pH 7.5), 150 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 10 % glycerol, 10 mM Na4P2O7, 10 mM 220 
NaF, 2 mM EDTA, 1 % Nonidet P-40, 2 mM Na3VO4, 5 μg/mL leupeptin, 20 μg/mL 221 
aprotinin, 2 mM benzamidin and 2 mM phenylmethylsulphonyl fluoride (PMSF)] to detect 222 
AKT, p-AKT, ERK1/2, p-ERKs, JNK1/2 and p-JNKs (Gavete, L. et al., 2005). Homogenates 223 
were centrifuged at 14000 xg for 60min and the supernatants were collected, assayed for 224 
protein concentration by using the Bradford reagent, aliquoted and stored at –80 ºC until use 225 
for Western blot analyses. 226 
 227 
Protein determination by Western Blotting 228 
Equal amounts of protein (100 µg) were separated by SDS-PAGE and transferred to 229 
polyvinylidene difluoride (PVDF) filters (Protein Sequencing Membrane, BioRad). 230 
Membranes were probed with the corresponding primary antibody followed by incubation 231 
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with peroxide-conjugated antirabbit Ig (GE Healthcare, Madrid, Spain). Blots were developed 232 
with the ECL system (GE Healthcare, Madrid, Spain). Normalization of Western blot was 233 
ensured by ß-actin and band quantification was carried out with a scanner and the Scion 234 
Image software. 235 
 236 
Statistics  237 
Prior to statistical analysis, data were tested for homogeneity of variances by the test of 238 
Levene. For multiple comparisons, one-way ANOVA was followed by the Bonferroni test 239 
when variances were homogeneous or by the Tamhane test when variances were not 240 
homogeneous. P<0.05 was considered significant. A SPSS version 15.0 program was used. 241 
242 
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Results 243 
 244 
Body and liver weights and food consumption 245 
Final body weights and food consumption decreased after DEN administration in all groups 246 
of animals (groups 3-5) (Table 2). Consistent with these results, body weight gains of groups 247 
1 and 2 were higher than those in DEN-injected groups. The lowest values were observed in 248 
group 5 corresponding to DEN-treated animals that received the cocoa-rich diet at day 28, 249 
after being fed with standard diet (Table 2). Therefore, the food efficiency diminished in 250 
groups 3-5 when compared to DEN-untreated animals (groups 1 and 2), and the smallest 251 
alimentary efficiencies were observed in DEN-rats receiving the cocoa-rich diet (groups 4 and 252 
5). 253 
Liver weights of group 5 were diminished when compared to all other groups of animals. 254 
However, no significant differences in liver-to-body weight ratio were observed among the 255 
experimental groups (Table 2). 256 
 257 
Levels of markers of liver function in serum 258 
As shown in Table 3, the serum total protein levels were reduced in DEN-treated rats, and 259 
were not normalized by the cocoa supplementation; on the contrary, group 5, in which diet 260 
was changed from standard to cocoa-rich one, showed the lowest values (Table 3). 261 
The serum activity of ALT exhibited an elevation in DEN-treated groups and remained 262 
increased in animals receiving cocoa-diet in comparison with untreated rats (Table 3). 263 
Addition of cocoa to DEN-injected animals (groups 4 and 5) showed an enhanced activity of 264 
AST when compared to untreated (groups 1 and 2) and DEN-treated (group 3) rats. Similarly, 265 
ALP activity was increased because of the administration of DEN in all experimental groups 266 
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(groups 3-5). However, only in cocoa-fed rats treated with DEN (group 4), an increase in 267 
GST activity was observed (Table 3). 268 
 269 
Levels of liver GSH and phase I and II enzymes 270 
Liver GSH concentration decreased by DEN administration in group 3, which showed the 271 
lowest levels (Figure 2). However, liver GSH content was elevated by cocoa in control and 272 
DEN-treated rats (groups 2 and 4, Figure 2), whereas animals fed with cocoa-diet for 2 weeks 273 
(group 5) displayed similar values to control DEN-untreated rats (group 1). 274 
Similar results were obtained for GPx activity, with increased values in the animals 275 
consuming cocoa for 6 weeks (groups 2 and 4), decreased GPx activity after DEN treatment 276 
in rats fed with standard diet (group 3), and recovering of control values in group 5. GR 277 
showed an increased activity in untreated animals fed cocoa (group 2), while all the DEN-278 
treated groups showed similar values to controls (group 1) (Figure 2). Similarly to GPx, 279 
catalase activity decreased in animals fed with standard diet and treated with DEN (group 3), 280 
whereas the other groups of rats displayed similar levels to controls (Figure 2). GST activity 281 
in liver remained unaltered in all animals except in group 4, where an increase in its activity 282 
was detected (Figure 2). Therefore, cocoa induces the antioxidant defence in the liver of the 283 
control and DEN-injected rats. 284 
 285 
Protein carbonyl content and LDH levels and caspase-3 activity in liver 286 
Levels of protein carbonyl content were increased in group 3 due to DEN administration 287 
when compared to no-injected animals (Figure 3). However, cocoa-fed rats treated with DEN 288 
(groups 4 and 5) showed a decreased protein carbonyl levels when compared to group 3, 289 
values were reverted to control levels in group 4 (cocoa-fed during 4 weeks) or partly 290 
diminished in group 5 (cocoa-fed for 2 weeks). 291 
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Lactate dehydrogenase levels were increased by DEN administration in all groups (groups 3-292 
5), pointing at a DEN-induced liver injury that was not prevented by the cocoa-rich diet 293 
(Figure 3). DEN also induced caspase-3 activity (group 3), but cocoa administration was 294 
capable of returning caspase-3 activity to control levels in animals consuming the cocoa-rich 295 
diet throughout the experiment (group 4), or partly decreased the DEN-induced activation of 296 
caspase-3 in animals receiving the cocoa-rich diet only for two weeks (group 5). Animals fed 297 
with the cocoa-rich diet (group 2) showed LDH levels similar to control rats and decreased 298 
values of caspase-3 activity (Figure 3). These results indicate that cocoa diminished the 299 
oxidative (carbonyl protein content) and apoptotic damages (caspase-3 activation), but not the 300 
necrotic DEN-induced liver injury (LDH activity). 301 
 302 
Liver AKT, ERK and JNK levels 303 
Figures 4 and 5 illustrate that DEN-treated animals fed with the standard diet (group 3) 304 
showed a significant increase in the levels of phosphorylated AKT and JNK proteins, whereas 305 
no changes in these two proteins were found in the other groups of animals. Phosphorylated 306 
ERK levels were increased by cocoa administration in control animals (group 2), but they 307 
were dramatically decreased by DEN treatment in all injected rats (groups 3-5) (Figure 5). 308 
There was no difference in the total levels of AKT, ERKs and JNKs among the groups. Thus, 309 
cocoa prevented the activation of AKT and JNK, although it did not modify the decreased 310 
values of active ERK induced by DEN. 311 
312 
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Discussion 313 
 314 
DEN toxicity is primarily associated to an excessive production of free radicals in the liver. 315 
As a consequence, reactive electrophilic intermediates are formed, which overwhelms the 316 
antioxidant defences and ultimately proceeds to oxidative stress paving way to liver damage 317 
(Kang, J. et al., 2007). DEN induces a postnecrotic hepatocellular proliferation that 318 
contributes to enhance the number of initiated cells (Cascales, M., 2001), and it is accepted as 319 
a model to study the relations among liver necrosis, cancer initiation and replication 320 
(Cascales, M., 2001, Chuang, S. et al., 2000, Köhle, C. et al., 2008, Ramakrishnan, G. et al., 321 
2006, Sivaramakrishnan, V. et al., 2008, Sreepriya, M. and Bali, G., 2005, Sreepriya, M. and 322 
Bali, G., 2006, Sundaresan, S. and Subramanian, P., 2008, Tessitore, L. and Bollito, E., 323 
2006). 324 
Cocoa and its derived products have been demonstrated to contain important antioxidant 325 
polyphenols that inhibit different tumoral processes and exhibit antioxidant and anti-326 
inflammatory properties (Amin, I. et al., 2004, Lamuela-Raventós, R. et al., 2005, Martin, M. 327 
et al., 2009, Martin, M. et al., 2008, Yamagishi, M. et al., 2000, Yamagishi, M. et al., 2002, 328 
Yamagishi, M. et al., 2003). In this study, we show that a cocoa-rich diet partly protect the 329 
liver against an oxidative-induced damage by decreasing the protein carbonyl content and 330 
modulating the activities of antioxidant enzymes and by regulating key proteins of cell 331 
signalling cascades, although cocoa-rich diet was unable to abrogate the DEN-induced 332 
enhanced values of hepatospecific enzymes and LDH. The cocoa dose was finally selected 333 
based on our own previous in vivo studies, where it is showed that it contributed to reduce the 334 
cardiovascular risk acting as an effective antioxidant (Lecumberri, E. et al., 2007). 335 
Reduction of food intake and consequently, the reduction of body weight gain observed in 336 
DEN-treated animals, could be largely due to losses from skeletal muscle and adipose tissue 337 
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as previously shown (Sreepriya, M. and Bali, G., 2005), and it could be considered as an 338 
indirect indication of the declining hepatic function following exposure to DEN (Amin, I. et 339 
al., 2004, Ramakrishnan, G. et al., 2006, Sivaramakrishnan, V. et al., 2008, Sreepriya, M. and 340 
Bali, G., 2005). In addition, assessment of the liver/body weights ratio was used to investigate 341 
potential changes in the liver size, but no differences were found (Ramakrishnan, G. et al., 342 
2006, Sreepriya, M. and Bali, G., 2005, Yamagishi, M. et al., 2003). 343 
Low levels of albumin have been reported in the serum of patients and animals with early 344 
hepatocellular cancer (Sreepriya, M. and Bali, G., 2005, Yoshida, H. et al., 2005). Contrary to 345 
other antioxidants such as curcumin and embelin that reverted the diminished serum proteins 346 
values induced by DEN (Sreepriya, M. and Bali, G., 2005), our results indicate that cocoa did 347 
not exhibit its protective effects during DEN-induced liver damage by enhancing the total 348 
protein levels. 349 
GSH is an important non-enzymatic antioxidant defence required to maintain the normal 350 
redox state of cells and to counteract deleterious effects of oxidative stress. GSH depletion 351 
ultimately promotes oxidative stress, with a cascade of effects thereby affecting functional 352 
and structural integrity of cell and organelle membrane (Masella, R. et al., 2005). Our results 353 
showed that the significant decrease in GSH levels in animals exposed to DEN was restored 354 
or enhanced by cocoa feeding, which indicated the potentiality of cocoa to counteract the 355 
oxidative damage induced by DEN and to reinforce the antioxidant defence in normal 356 
conditions, as previously reported for other natural antioxidants (Ramakrishnan, G. et al., 357 
2006, Sivaramakrishnan, V. et al., 2008, Sreepriya, M. and Bali, G., 2006). 358 
Chemical induction of liver damage by DEN administration is associated with changes in the 359 
oxygen radical metabolism in this organ, which were demonstrated by measuring protein 360 
carbonyl content and the activity of the antioxidant enzymes. Generation of protein, DNA and 361 
lipid oxidation products by DEN administration at the initiation stage can be prevented by 362 
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natural antioxidants (Ramakrishnan, G. et al., 2006, Sivaramakrishnan, V. et al., 2008, 363 
Sreepriya, M. and Bali, G., 2006). Thus, DEN-treated rats fed with cocoa (groups 4 and 5) 364 
displayed lower levels of protein carbonyl content when compared with rats injected with 365 
DEN receiving regular diet (group 3). This reveals the protective role of cocoa against the 366 
induced-oxidative stress (Lecumberri, E. et al., 2007, Martin, M. et al., 2008, Ramiro-Puig, E. 367 
et al., 2009). 368 
Catalase converts H2O2 to H2O and GPx catalyses the transformation of H2O2 to harmless 369 
byproducts. During H2O2 scavenging, GSH is oxidized to GSSG by GPx. The reduction of 370 
GSSG to GSH is catalysed by GR using NADPH as reducing potential. GPx and GR 371 
activities were increased and catalase activity was unchanged in control animals fed cocoa in 372 
agreement with our previous results, where the induction of both enzymatic activities by a 373 
cocoa polyphenolic extract (Martin, M. et al., 2009) and a cocoa fibre byproduct (Lecumberri, 374 
E. et al., 2007) was demonstrated. The decrease of GSH levels and GPx and catalase activities 375 
indicates the severity of the oxidative stress induced during the exposure to DEN. 376 
Interestingly, cocoa counteracted the hepatic oxidative damage by preventing the reduction of 377 
these parameters provoked by DEN. In line with this, decreases in GSH levels, as well as in 378 
activities of catalase, GPx and GR, have been reported in hepatic tumours (Ramakrishnan, G. 379 
et al., 2006, Sivaramakrishnan, V. et al., 2008, Sreepriya, M. and Bali, G., 2006). 380 
GST catalyses the reaction of endogenous GSH with numerous electrophiles to yield less 381 
toxic conjugates that are easily eliminated (Masella, R. et al., 2005). Although increased and 382 
decreased liver and serum GST activities have been reported after DEN-induced damage 383 
(Amin, I. et al., 2004, Sivaramakrishnan, V. et al., 2008, Sreepriya, M. and Bali, G., 2006, 384 
Sundaresan, S. and Subramanian, P., 2008, Yadav, A. and Bhatnagar, D., 2007), we found 385 
that liver and serum GST activities increased in rats fed with cocoa and injected with DEN 386 
(group 4), suggesting that cocoa administration contributes to the liver protection against the 387 
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oxidative induced-injury. In this regard, it has been demonstrated that different natural 388 
compounds and polyphenols, as well a cocoa bean product, induce GST as one of the 389 
principal anticarcinogenic mechanisms (Amin, I. et al., 2004, Masella, R. et al., 2005, 390 
Sundaresan, S. and Subramanian, P., 2008). Moreover, some studies point to the induction of 391 
GST as a mechanism to protect against chemically induced cancer and oxidative stress by 392 
increasing the metabolism of electrophilic intermediates and ROS (Masella, R. et al., 2005). 393 
Enhancement of liver LDH activity, a sensitive marker of hepatocyte injury, indicates a 394 
nonspecific alteration in the plasma membrane integrity and permeability and/or may be due 395 
to its overproduction by tumour cells (Kamaraj, S. et al., 2007, Manso, M. et al., 2007, 396 
Sivaramakrishnan, V. et al., 2008). The significant DEN-induced increase in serum hepatic 397 
marker enzymes and liver LDH activities that indicated the hepatocellular dysfunction and the 398 
severity of the liver necrotic damage (Amin, I. et al., 2004, Kamaraj, S. et al., 2007, 399 
Sivaramakrishnan, V. et al., 2008), were not avoided by the administration of a cocoa-rich 400 
diet. 401 
Activation of caspase-3, the most important enzyme responsible for apoptosis, has been 402 
considered as a sensitive method of detecting liver damage and has been associated with 403 
progressive liver fibrosis (Bantel, H. et al., 2004). Moreover, high rates of apoptosis have 404 
been demonstrated in liver cancer (Kang, J. et al., 2007, Schimtz, K.J. et al., 2007). In 405 
addition, it should be mentioned that administration of DEN (200 mg/Kg) causes fibrosis and 406 
necrosis in the liver (Tessitore, L. and Bollito, E., 2006). It is noticeable that DEN-injected 407 
rats fed with standard diet (group 3) showed levels of AST and ALT that were below those of 408 
the other DEN-treated groups. This finding could be a consequence of a reduction in the 409 
number of viable hepatocytes due to enhanced cell death in liver, as these animals also 410 
showed the highest levels of LDH and caspase-3 (Manso, M. et al., 2007). Thus, the 411 
decreased caspase-3 activity in animals not injected with DEN and fed with cocoa (group 2), 412 
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as well as in DEN-treated rats receiving cocoa (groups 4 and 5), suggested a potential 413 
protective effect of cocoa against cell death in normal and under oxidative conditions. 414 
Therefore, although additional studies are needed, it could be suggested that cocoa could 415 
partly protected hepatocytes against the progression of the fibrotic damage induced by DEN. 416 
The signalling mechanisms associated with liver damage induced by oxidative-stress are not 417 
completely known. In our study, the increase in p-AKT levels in DEN-treated rats fed the 418 
standard diet (group 3) agrees with that reported in animals receiving DEN in drinking water 419 
(Parekh, P. and Rao, K.V.K., 2007). These data support the important role of AKT in 420 
controlling the balance between survival and apoptosis (Ramos, S., 2008), which has been 421 
considered a critical factor in the aggressiveness of hepatocellular cancer (Parekh, P. and Rao, 422 
K.V.K., 2007, Schimtz, K.J. et al., 2007). Moreover, the value of p-AKT was restored in rats 423 
injected with DEN but fed cocoa (groups 4 and 5) suggests that cocoa prevents the activation 424 
of this main protein related to cell survival/proliferation; this could result in a potential 425 
attenuation of the postnecrotic proliferation induced by DEN and in a reduction of the number 426 
of initiated cells (Cascales, M., 2001). 427 
ERK plays a critical role in controlling the balance between cell survival and proliferation, 428 
and cell cycle progression (Schimtz, K.J. et al., 2007). Although data on p-ERK values 429 
remain controversial (Ito, Y. et al., 1998, Parekh, P. and Rao, K.V.K., 2007), increased p-430 
ERK levels have recently been related to an advanced, but not early, tumour stage (Huynh, H. 431 
et al., 2003). This finding supports our results, since decreased levels of p-ERK were found in 432 
all DEN-injected animals, a model to study the relations among necrosis and cancer initiation. 433 
Moreover, p-ERK was increased in rats fed a cocoa-rich diet indicating that cocoa 434 
components can activate cellular kinases (Ramos, S., 2008) in concert with our previous 435 
results (Granado-Serrano, A. et al., 2007, Martin, M. et al., 2009, Ramiro-Puig, E. et al., 436 
2009). Similarly, the enhanced levels of p-ERK in cocoa fed rats (group 2) could be related to 437 
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their increased GR and GPx activities, since MAPKs pathway has recently been implicated in 438 
the up-regulation of several antioxidant enzymes activities in liver cancer cells (Martin, M. et 439 
al., 2009). 440 
The JNK family belongs to the MAPKs superfamily (same as ERKs) and its activation has 441 
been associated to apoptosis in liver (Czaja, M., 2003, Parekh, P. and Rao, K.V.K., 2007). 442 
DEN administration enhanced the p-JNK/JNK ratio in animals fed with the standard diet 443 
(group 3) and returned to control values in DEN-groups receiving cocoa (groups 4 and 5). In 444 
line with this, a protective effect of cocoa flavonoids has been described on a model of 445 
oxidative stress in neurons, showing a down-regulation of p-JNK levels (Ramiro-Puig, E. et al., 446 
2009). Moreover, DEN-treated rats fed with regular diet showed the highest LDH and caspase-447 
3 activities and p-JNK/JNK values, pointing out to an enhanced cell death in the liver of these 448 
animals, although this group also exhibited enhanced p-AKT values suggestive of a promotion 449 
of cellular survival/proliferation. At the moment we cannot explain this finding and further 450 
studies are needed to elucidate this result, but similar effects have been reported in patients 451 
with liver cancer (Kang, J. et al., 2007, Schimtz, K.J. et al., 2007). 452 
Finally, it is important to mention that in vitro studies have attributed the protective effect of 453 
cocoa to the polyphenols, since the contribution of theobromine was considered negligible 454 
(Martin, M. et al., 2008). Additionally, a similar protective effect has been recently described 455 
after treating cells with a cocoa phenolic extract or (-)-epicatechin (Ramiro-Puig, E. et al., 456 
2009). Therefore, it could be suggested that the beneficial effects of cacao in the present study 457 
might be ascribed to the polyphenolic compounds, which even may develop synergism among 458 
them, but further studies are needed. 459 
In summary, a cocoa-rich diet protects cells against DEN-induced oxidative stress by activating 460 
the antioxidant defence system. In addition, cocoa appears to exert an antiapoptotic effect in 461 
the liver of DEN-treated animals that could be associated with the prevention of JNK and 462 
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caspase-3 activation. Cocoa also prevented the DEN-induced increase of the 463 
survival/proliferation signal AKT, associated with poor prognosis in liver cancer. All these 464 
effects contribute to attenuate the liver DEN-induced oxidative damage. However, cocoa was 465 
not completely capable of avoiding the liver necrotic damage induced by the hepatotoxic as 466 
shown by the increased activities of the hepatospecific enzymes and LDH as well as decreased 467 
p-ERK values. These results provide new insights into the antioxidative mechanisms of cocoa 468 
flavonoids and point towards their antiapoptotic and modulatory effects on cell death and 469 
survival/proliferation pathways as additional mechanisms of action of these compounds. 470 
Therefore, it could be suggested that cocoa or cocoa products enriched in flavonoids, which 471 
lack of toxicity in humans, may contribute to the protection against liver oxidative stress-472 
related diseases. 473 
474 
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Figure Captions 640 
 641 
Figure 1. Schematic representation of the experimental design used for the study. 642 
 643 
Figure 2. Effect of cocoa on (A) glutathione levels and activity of (B) GPx, (C) GR, (D) CAT 644 
and (E) GST liver from control and DEN groups fed with standard (C) and cocoa-rich (Ca) 645 
diets. Data represent the means  SD (n=8-10). Means without a common letter differ, P< 646 
0.05. 647 
 648 
Figure 3. Liver (A) protein carbonyl, (B) LDH and (C) caspase-3 levels in control and DEN 649 
groups fed with standard (C) and cocoa-rich (Ca) diets. Data represent the means  SD (n=6-650 
8). Means without a common letter differ, P< 0.05. 651 
 652 
Figure 4. Effect of cocoa on levels of phosphorylated AKT (Ser473) and total AKT in 653 
controls and DEN-treated rats. (A) Bands of a representative experiment. (B) Percentage 654 
values of the p-AKT/AKT ratio relative to the control condition (means  SD, n=6). 655 
Normalization of Western blots was ensured by β-actin. Means without a common letter 656 
differ, P< 0.05. 657 
 658 
Figure 5. Effects of cocoa on the basal levels of phosphorylated ERK1/2 (Thr202/Tyr204), 659 
total ERK1/2, phosphorylated JNK1/2 (Thr183/Tyr185) and total JNK in controls and DEN-660 
treated animals. (A) Representative blots of both MAPKs. Percentage data of (B) p-661 
ERK/ERK and (C) p-JNK/JNK ratios relative to controls (means  SD, n=7). The same liver 662 
homogenates were subjected to Western blot analysis using the corresponding non-phospho-663 
Protective effects of cocoa in liver damage 
 31 
specific antibodies to detect total ERK or JNK. Equal loading of Western blots was ensured 664 
by β-actin. Means without a common letter differ, P< 0.05. 665 
666 
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Table 1. Composition of the experimental control (C) and cocoa-rich (Ca) diets (g/Kg 667 
dry weight). 668 
  
C 
 
Ca 
Casein 140 140 
Dextrose 155 155 
Sucrose 100 100 
Fat 40 40 
t-BHQ
1 
0.008 0.008 
Mineral mix. 35 35 
Vitamin mix. 10 10 
L-Cys 1.8 1.8 
Cholin bitartrate 2.5 2.5 
Cellulose 100 45.6 
Starch 415.7 310.1 
Cocoa powder - 160 
 669 
1
 
 
tert-butylhydroquinone 670 
 671 
Protective effects of cocoa in liver damage 
 33 
Table 2. Body weight data, food intake and liver weight of rats in control and DEN groups fed with standard (C) and cocoa-rich (Ca) diets*. 672 
 673 
 674 
 675 
 676 
 677 
 678 
 679 
 680 
 681 
 682 
 683 
 684 
* Data represent the means  SD. Means in a row without a common letter differ, P< 0.05. 685 
 
Control groups DEN groups 
 1 (C) 
2 (Ca)  
3 (C) 4(Ca) 5(C-Ca) 
Initial body weight (g) 95.00  4.69a 92.57  3.41a 102.75  8.87a 104.00  7.77a 105.88  5.2 a 
Body weight on day 14 (g) 135.17  3.81a 134.00  7.83a 135.00  5.58a 134.33  6.68a 137.75  7.89a 
Final body weight (g) 205.83  10.21a 202.14  6.36a 183.17  8.18b 175.71  12.09bc 161.29  10.81c 
Body weight gain (g in 42d) 110.83  7.92a 110.57  4.58a 81.20  8.32b 71.71  16.98bc 57.67  17.15c 
Food Intake (g in 42d) 574.58  3.66a 574.40  6.31a 529.58  25.66b 534.91  10.78b 531.91  16.53b 
Food Efficiency 
(Body weight gain/Food intake) 
0.19  0.02a 0.19  0.01a 0.16  0.02b 0.13  0.02c 0.11  0.03c 
Liver weight (g) 4.32  0.28a 4.42  0.28a 4.32  0.17a 4.20  0.22ab 3.79  0.14b 
Liver-to body weight ratio 0.021  0.002a 0.022  0.002a 0.022  0.001a 0.024  0.002a 0.023  0.002a 
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Table 3. Serum levels of total protein and activity of hepatic enzymes in control and DEN groups fed with standard (C) and cocoa-rich (Ca) diets*. 686 
 687 
 688 
 689 
 690 
 691 
 692 
 693 
 694 
 695 
* Data represent the means  SD. Means in a row without a common letter differ, P< 0.05. 696 
 
Control groups DEN groups 
 1 (C) 
2 (Ca)  
3 (C) 4 (Ca) 5 (C-Ca) 
Total protein (mg/mL) 112.09  11.61a 119.09  12.87a 80.16  11.65b 80.96  10.43b 76.35  16.55b 
ALT (U/L) 51.50  10.67a 59.29  12.47ab 75.50  12.33bc 85.00  6.73cd 86.75  8.54d 
AST (U/L) 284.80  41.84a 278.17  32.18a 265.17  28.99a 479.67  83.46b 435.33  67.33b 
ALP (U/L) 202.00  20.82a 221.00  25.91a 338.33  33.43b 315.00  47.93b 342.20  54.67b 
GST (mU/mg protein) 0.58  0.07a 0.46  0.08a 0.56  0.09ab 0.71  0.07b 0.49  0.09a 
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Figure 1. 697 
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Figure 2. 702 
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Figure 3. 704 
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Figure 4. 708 
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Figure 5. 712 
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